eli lilly vials of tirzepatide launched a four-dose, single-patient use KwikPen device for its injectable obesity drug, (Zepbound). The device gives patients an additional, potentially more convenient option for taking the drug: They can Lilly Launches Additional Zepbound Vial

Contraindicated in patients with active malignancy, uncontrolled diabetes, or certain medical conditions

If permitted by your insurance and supply availability, maintaining a backup pen can help avoid missed doses due to supply interruptions or pharmacy delays

GLP-1 drugs address only one type of inflammation

The provider you choose directly impacts your safety, your experience, and your results

Together, they bring decades of expertise, an unwavering commitment to excellence, and a shared passion for helping people look and feel their absolute best

Differences across groups were tested using ANOVA with a Tukey post hoc test when more than two experimental groups were analysed and using Students t-test when only two experimental groups were compared